Cargando…

Interferon-free treatments in patients with hepatitis C genotype 3 infection in a tertiary hospital

INTRODUCTION: Hepatitis C virus genotype 3 represents a unique entity within HCV treatment and multiple studies have documented that HCV genotype 3 infection is associated with more rapid disease progression than other genotypes, resulting in increased risk of cirrhosis, hepatocellular carcinoma, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	del Rio-Valencia, Juan Carlos, Asensi-Diez, Rocío, Madera-Pajin, Raquel, Yunquera-Romero, Lucía, Muñoz-Castillo, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2018
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159354/ https://www.ncbi.nlm.nih.gov/pubmed/29376623

Ejemplares similares

Direct-actng antiviral agents in patients with hepatitis C genotype 1-4 infections in a tertiary hospital
por: del Rio-Valencia, Juan Carlos, et al.
Publicado: (2018)

Effectiveness of 12 week ledipasvir/sofosbuvir and predictors of treatment failure in patients with hepatitis C
por: del Rio-Valencia, Juan Carlos, et al.
Publicado: (2019)

Adecuación de las prescripciones antimicrobianas realizadas en el área de urgencias de un hospital de tercer nivel
por: Yunquera-Romero, Lucia, et al.
Publicado: (2018)

Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
por: FakhriRavari, Alireza, et al.
Publicado: (2016)

Diagnóstico al alta y causas de mortalidad de pacientes VIH+ ingresados en un hospital de tercer nivel
por: Asensi-Diez, Rocío, et al.
Publicado: (2019)

Cost-utility analysis of interferon-free treatments for patients with early-stage genotype 1 hepatitis C virus in Brazil
por: Ferreira, Vinicius Lins, et al.
Publicado: (2020)

Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting
por: Ramos, Huascar, et al.
Publicado: (2017)

Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen
por: Ahmed Sakr, Ayman, et al.
Publicado: (2017)

Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
por: Endo, Daisuke, et al.
Publicado: (2017)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2019)

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element
por: Guo, Yanan, et al.
Publicado: (2019)

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection
por: Venugopal, Vishnu, et al.
Publicado: (2018)

Hepatitis C Virus Infection: Looking for Interferon Free Regimens
por: González-Moreno, J., et al.
Publicado: (2013)

The New Era of Interferon-Free Treatment of Chronic Hepatitis C
por: Solbach, Philipp, et al.
Publicado: (2015)

The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy
por: Pang, Phillip S., et al.
Publicado: (2009)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4
por: Motawi, Tarek Kamal, et al.
Publicado: (2015)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes, Jacinta A, et al.
Publicado: (2015)

Response Guided Interferon Therapy for Genotype 3 of Chronic Hepatitis C: Compliance and Outcome
por: Sarwar, Shahid, et al.
Publicado: (2015)

Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine
por: Mandrik, Olena, et al.
Publicado: (2014)

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
por: Chaturvedi, Nimisha, et al.
Publicado: (2019)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital
por: Bhumbla, Upasana, et al.
Publicado: (2020)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
por: Sung, Pil Soo, et al.
Publicado: (2018)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

High Dose of Pegylated Interferon for the Treatment of Chronic Hepatitis B in Children Infected With Genotype C
por: Komatsu, Haruki, et al.
Publicado: (2020)

Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review
por: Mucenic, Marcos, et al.
Publicado: (2019)

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
por: Rivero-Juarez, A., et al.
Publicado: (2015)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
por: Urbanowicz, Arkadiusz, et al.
Publicado: (2018)

Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapies
por: Siqueira, Fabiane Mateus, et al.
Publicado: (2018)

Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
por: Nemteanu, Roxana, et al.
Publicado: (2023)

Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
por: Kim, Do Young
Publicado: (2014)

Factors influencing therapeutic response to pegylated interferon plus ribavirin in the different genotypes of chronic hepatitis C
por: Heidari, Mehdi, et al.
Publicado: (2014)

Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
por: Abdel-Moneim, Adel, et al.
Publicado: (2018)

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
por: Goyal, Ashish, et al.
Publicado: (2018)

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis
por: Badra, Gamal, et al.
Publicado: (2006)

Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bh9p3dq4tlj628aurl568njlof